Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (24)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rush, J. S.
Right arrow Articles by Freeze, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rush, J. S.
Right arrow Articles by Freeze, H. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Glycobiology, 2000, Vol. 10, No. 8 829-835
© 2000 Oxford University Press

Mannose supplementation corrects GDP-mannose deficiency in cultured fibroblasts from some patients with Congenital Disorders of Glycosylation (CDG)

Jeffrey S. Rush3, K. Panneerselvam1,4, Charles J. Waechter3 and Hudson H. Freeze2,4

3Department of Biochemistry, A.B.Chandler Medical Center, University of Kentucky College of Medicine, Lexington, KY and 4The Burnham Institute, La Jolla, CA 92037 USA

Congenital Disorders of Glycosylation (CDG) are human deficiencies in glycoprotein biosynthesis. Previous studies showed that 1 mM mannose corrects defective protein N-glycosylation in cultured fibroblasts from some CDG patients. We hypothesized that these CDG cells have limited GDP-mannose (GDP-Man) and that exogenous mannose increases the GDP-Man levels. Using a well established method to measure GDP-Man, we found that normal fibroblasts had an average of 23.5 pmol GDP-Man/106 cells, whereas phosphomannomutase (PMM)-deficient fibroblasts had only 2.3–2.7 pmol/106 cells. Adding 1 mM mannose to the culture medium increased the GDP-Man level in PMM-deficient cells to approximately 15.5 pmol/106 cells, but had no significant effect on GDP-Man levels in normal fibroblasts. Similarly, mannose supplementation increased GDP-Man from 4.6 pmol/106 cells to 24.6 pmol/106 cells in phosphomannose isomerase (PMI)-deficient fibroblasts. Based on the specific activity of the GDP-[3H]Man pool present in [2-3H]mannose labeled cells, mannose supplementation also partially corrected the impaired synthesis of mannosylphosphoryldolichol (Man-P-Dol) and Glc0-3Man9GlcNAc2-P-P-Dol. These results confirm directly that deficiencies in PMM and PMI result in lowered cellular GDP-Man levels that are corrected by the addition of mannose. In contrast to these results, GDP-Man levels in fibroblasts from a CDG-Ie patient, who is deficient in Man-P-Dol synthase, were normal and unaffected by mannose supplementation even though mannose addition was found to correct abnormal lipid intermediate synthesis in another study (Kim et al. [2000] J. Clin. Invest., 105, 191–198). The mechanism by which mannose supplementation corrects abnormal protein N-glycosylation in Man-P-Dol synthase deficient cells is unknown, but this observation suggests that the regulation of Man-P-Dol synthesis and utilization may be more complex than is currently understood.

1 Present address: Glycobiology Research and Training Center, University of California San Diego School of Medicine, La Jolla, CA 92093

2 To whom correspondence should be addressed at: The Burnham Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
GlycobiologyHome page
M. A Lehrman
Teaching dolichol-linked oligosaccharides more tricks with alternatives to metabolic radiolabeling
Glycobiology, August 1, 2007; 17(8): 75R - 85R.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Thiel, T. Lubke, G. Matthijs, K. von Figura, and C. Korner
Targeted Disruption of the Mouse Phosphomannomutase 2 Gene Causes Early Embryonic Lethality
Mol. Cell. Biol., August 1, 2006; 26(15): 5615 - 5620.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
E. Lamani, R. B. Mewbourne, D. S. Fletcher, S. D. Maltsev, L. L. Danilov, V. V. Veselovsky, A. V. Lozanova, N. Ya. Grigorieva, O. A. Pinsker, J. Xing, et al.
Structural studies and mechanism of Saccharomyces cerevisiae dolichyl-phosphate-mannose synthase: insights into the initial step of synthesis of dolichyl-phosphate-linked oligosaccharide chains in membranes of endoplasmic reticulum
Glycobiology, July 1, 2006; 16(7): 666 - 678.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Gao, J. Shang, and M. A. Lehrman
Analysis of Glycosylation in CDG-Ia Fibroblasts by Fluorophore-assisted Carbohydrate Electrophoresis: IMPLICATIONS FOR EXTRACELLULAR GLUCOSE AND INTRACELLULAR MANNOSE 6-PHOSPHATE
J. Biol. Chem., May 6, 2005; 280(18): 17901 - 17909.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Shang and M. A. Lehrman
Metformin-stimulated Mannose Transport in Dermal Fibroblasts
J. Biol. Chem., March 12, 2004; 279(11): 9703 - 9712.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
N. Gao and M. A. Lehrman
Analyses of dolichol pyrophosphate-linked oligosaccharides in cell cultures and tissues by fluorophore-assisted carbohydrate electrophoresis
Glycobiology, May 1, 2002; 12(5): 353 - 360.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
H. H. Freeze
Update and perspectives on congenital disorders of glycosylation
Glycobiology, December 1, 2001; 11(12): 129R - 143R.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. Westphal, S. Murch, S. Kim, G. Srikrishna, B. Winchester, R. Day, and H. H. Freeze
Reduced Heparan Sulfate Accumulation in Enterocytes Contributes to Protein-Losing Enteropathy in a Congenital Disorder of Glycosylation
Am. J. Pathol., December 1, 2000; 157(6): 1917 - 1925.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.